GlassScriptPhysician profile
Steven M Knapik
NPI 1992882955
$1,355.62
in general payments reported to CMS, 2019-2025
21 companies · $42.22 in 2025
The $42.22 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.86 · 2020: $439 · 2021: $340 · 2022: $250 · 2023: $69.46 · 2024: $120 · 2025: $42.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $483.91 | 2020-2023 | |
| Amgen INC. | $151.24 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $93.40 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.15 | 2020-2022 | |
| Novo Nordisk INC | $66.53 | 2020-2024 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $60.29 | 2024 | Cologuard Collection Kit |
| Eisai INC. | $49.54 | 2020 | |
| Smith+Nephew, INC. | $47.89 | 2019-2020 | |
| Verona Pharma, INC. | $42.22 | 2025 | Ohtuvayre |
| Astrazeneca Pharmaceuticals LP | $41.82 | 2022-2024 | Farxiga |
| Avion Pharmaceuticals | $33.90 | 2022 | |
| Alkermes, INC. | $33.13 | 2019-2022 | |
| Lilly USA, LLC | $24.60 | 2022 | |
| Glaxosmithkline, LLC. | $22.70 | 2021 | |
| Abbott Laboratories | $22.66 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $20.33 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.98 | 2023 | Quviviq |
| Abbvie INC. | $17.03 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $16.44 | 2019 | |
| Hologic Sales and Service, LLC | $15.39 | 2023 | Thinprep 2000 Processor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Knapik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.